Gene Query: FOXK2

Dataset Description Geneva Score
RNA transcriptome analysis during HSV-1 infection 34.19
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 26.8
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 26.31
MOF acetyl transferase regulates transcription and respiration in mitochondria 26.2
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 23.29
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 23.29
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 22.04
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 20.85
CD95/Fas ligand mRNA is toxic to cells 20.72
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 20.63
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 20.63
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 20.14
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 20.14
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 19.85
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 19.38
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 17.99
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 17.99
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 17.49
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 17.34
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 16.68
RNA-seq analysis of BAP1-depleted uveal melanoma cells 15.98
EWSR1 influences alternative splicing through direct and indirect mechanisms 15.98
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 15.96
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 15.2
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 14.86
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 14.78
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 14.67
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 14.6
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 14.6
Neurofibroma 14.32
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 14.32
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 14.24
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 13.75
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 13.63
RNA sequencing of GlyH-101-treated MCF-7 cell line 13.51
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 13.24
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 13.24
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.09
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 12.91
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.8
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 12.65
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 12.54
Illumina Total RNA-seq in HeLa 12.5
Role of XRN2 ribonucleolytic activity in RNA metabolism 12.13
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 12.08
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.79
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 11.7
An integrative analysis of non-coding regulatory DNA variations associated with autism 11.6
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 11.57
DART-seq: an antibody-free method for global m6A detection 11.46
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 11.3
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 11.16
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 11.02
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.01
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 11.0
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.96
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.96
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 10.93
TGF-β regulation of miRNA expression in pancreatic cancer 10.68
The evolution of N6-methyladenosine in primates 10.6
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.57
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.57
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 10.55
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 10.49
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 10.48
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 10.41
ETV7 and interferon response 10.38
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 10.38
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.31
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 10.21
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 9.94
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 9.91
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 9.83
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 9.71
Studying the selectivity of a small molecule Synucleozid on transcriptome 9.54
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.48
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.48
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.35
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.35
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 9.29
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 9.28
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.25
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.15
The transcriptome effect of overexpressing EZH2 in MCF7 9.12
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 9.11
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 9.07
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.94
Cleavage Factor Im as a key regulator of 3’ UTR length 8.91
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.86
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 8.84
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.83
RNA-seq analyisis of PUM2 knockout cells 8.8
RNA-seq of human aneuploid cell lines with Trisomy 21 8.78
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.63
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.63
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.58
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.58
RNA-seq in HepG2 and IMR90 cells 8.45
Evolution of a transcriptional regulator from a transmembrane nucleoporin 8.45
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.38
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.33
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.32
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 8.29
Effect of drugs on transcriptomic profiles 8.29
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.26
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 8.16
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 8.16
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 8.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 8.13
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 8.13
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 8.1
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 7.98
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 7.96
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 7.8
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 7.74
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.73
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.7
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 7.69
Knockdown of ADNP in HCT116 colon cancer cells 7.65
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.63
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 7.63
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 7.61
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 7.61
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 7.58
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.54
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.5
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.46
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 7.46
Interphase condensins regulate ligand-depedent enhancer activation 7.46
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.44
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.44
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.43
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.37
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 7.33
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.31
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 7.31
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 7.27
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 7.27
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.25
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.25
RNAseq analysis of ESRP regulated splicing events in prostate cancer 7.22
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 7.21
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.2
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 7.19
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.17
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.15
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 7.1
A role for ZNF598 in post-transcriptional gene regulation 7.1
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 7.07
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 7.03
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 7.01
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.98
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.95
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.95
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.93
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 6.8
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.74
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.74
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 6.72
Seletive inhibition of CDK9 in DLBCL cell lines 6.65
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.63
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.61
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.6
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.59
CDK12 mediated transcriptional regulation in U2OS cells 6.56
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.51
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 6.48
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.48
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.47
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.47
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.47
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.46
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 6.37
The regulartory role of ZCCHC24 in splicing machinery 6.34
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.34
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.32
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 6.3
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 6.3
The interplay between SOX4 and SMAD3 in the context of breast cancer 6.29
RNA sequencing of primary human platelets and in vitro cell lines 6.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.26
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.25
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 6.23
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.22
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.21
Systematic discovery of endogenous human ribonucleoprotein complexes 6.16
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.16
m6A-dependent regulation of messenger RNA stability 6.16
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 6.09
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 6.07
RNA-sequencing in irradiated and normal A549 cells. 6.05
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 6.02
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.97
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 5.96
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.94
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.93
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 5.87
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.87
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.83
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 5.83
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 5.78
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.75
Landscape and variation of RNA secondary structure across the human transcriptome 5.73
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 5.72
CD73 knockdown effect in pancreatic cancer cell lines 5.72
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 5.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.71
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.71
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 5.7
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 5.7
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.67
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 5.63
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.56
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.54
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.52
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 5.52
NKX2.2 5.52
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.52
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.5
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.5
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 5.49
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 5.48
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.47
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.46
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.46
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.46
Human HAP1 cells before and after nutrient deprivation 5.46
PRDM1 inhibits proliferation of human colon cancer organoids 5.45
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 5.45
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.44
Uridylation by TUT4 and TUT7 marks mRNA for degradation 5.44
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.44
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 5.44
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.43
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.42
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 5.42
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 5.42
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.4
Human embryonic stem cells in E8 and AKIT culture medium 5.4
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 5.29
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 5.27
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.26
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 5.26
Hepatitis C virus functionally sequesters miR-122 5.26
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.22
Global response to chemotherapy-induced apoptosis 5.19
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.17
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 5.17
Effect of FGF13 depletion on the H460 cell line 5.16
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.16
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.16
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 5.07
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.03
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 4.99
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 4.99
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.93
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.88
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.84
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.82
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.8
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.79
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 4.74
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.72
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.68
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.64
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 4.63
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.61
Ebola virus (EBOV) infection of ARPE-19 cells 4.6
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.58
MARS Seq data from human cortical organoids 4.56
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.53
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.53
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.52
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.51
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.49
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.45
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.39
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.34
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.34
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.31
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.3
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 4.29
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.28
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.27
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.22
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 4.21
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.16
Transcriptome sequencing of K-562 cells 4.16
SLIGRL-induced gene expression changes in NHEK cells 4.14
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.13
High-throughput sequencing of pluripotent cells 4.1
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.04
METTL3 and WTAP 4.03
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.02
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 4.0
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.98
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.97
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.95
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.95
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.93
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.92
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.89
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.81
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.81
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 3.77
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.73
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.71
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 3.71
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.69
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.67
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.67
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.66
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.64
Expression profiling of MCF-7 cells with treatment of TCDD 3.64
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 3.63
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.62
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.6
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.57
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.57
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.55
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.55
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 3.51
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.4
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.33
Mapping interactions for the TNIP2 hub protein 3.33
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.28
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.21
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.19
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.18
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.16
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.16
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.14
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 3.08
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 3.08
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.03
Global analyses of the effect of different cellular contexts on microRNA targeting 3.02
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.02
RNA Seq of HMVEC under hypoxia 3.01
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.01
Gene expression profiling in metabolically heterogeneous human lung tumors 3.01
Functional role of CPPED1 in trophoblasts. 2.99
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.99
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.97
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 2.97
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.82
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.81
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.81
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.81
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.78
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.77
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.73
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.72
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.7
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.66
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.63
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.63
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.62
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.61
Comparative Analysis of Cas9 Activators Across Multiple Species 2.57
Gene expression profile in breast cancer cells 2.54
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.54
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.52
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.5
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.49
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.49
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.43
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.41
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.39
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.39
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 2.37
Capturing the Interactome of Newly Transcribed RNA 2.34
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.34
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.29
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.29
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.28
Induced DNA demethylation, genome instability and transcription 2.27
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.27
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.26
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.25
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.22
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 2.19
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.18
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 2.17
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.17
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.15
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.15
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.14
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.1
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.09
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.08
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 2.08
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 2.08
Determining mRNA half-lives on a transcriptome-wide scale 2.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.06
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.06
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.06
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.01
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 1.97
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.95
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.91
SRSF1 role in cellular gene expression and splicing 1.89
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.75
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.73
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.7
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.65
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.59
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.59
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.59
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.55
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.54
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  1.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.49
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.48
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.47
Transcriptome analysis of CNS leukemia 1.47
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.47
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.45
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.44
HEK293 TFAM Knockout Expression Study 1.43
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.43
Hepatocyte maturation 1.41
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.38
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.38
Ribosome profiling upon inhibition of eIF4A 1.36
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.3
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.3
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.3
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.3
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.28
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.26
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.23
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.22
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.16
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.13
Myc activation coordinates gene transcription and protein translation responses 1.1
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.09
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.05
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.05
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.04
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.03
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.02
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.01
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.01
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.98
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.95
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.94
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.94
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.92
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.9
RNA-seq data 0.9
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.88
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.87
Transposon-based construction of strand-specific RNA-seq libraries 0.83
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.81
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.81
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.78
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.76
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.76
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.76
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.75
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.74
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.7
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 0.67
The DPYSL2 gene connects mTOR and schizophrenia 0.66
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.62
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.57
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.56
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.56
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.56
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.55
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.52
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.49
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.39
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.36
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.35
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.32
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.32
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.28
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.26
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.26
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.21
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.2
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.2
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.19
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.16
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.16
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.16
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.16
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.13
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.08
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.05
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.05
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.02
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation